Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut.
Semin Thromb Hemost. 2018 Feb;44(1):52-56. doi: 10.1055/s-0037-1603938. Epub 2017 Aug 4.
The presence of a central venous catheter and admission to the intensive care unit are the most important risk factors for deep venous thrombosis (DVT) in children. At least 18% of critically ill children with a catheter develop radiologically confirmed catheter-associated thrombosis. Clinically apparent thrombosis occurs in 3% of critically ill children with a catheter and is associated with 8 additional days of mechanical ventilation. Even when the thrombus is initially asymptomatic, 8 to 18% of critically ill children with catheter-associated thrombosis develop postthrombotic syndrome. Thrombosis is uncommon within 24 hours after insertion of a nontunneled catheter in critically ill children, but nearly all thrombi have developed by 4 days after insertion. Hypercoagulability during or immediately after insertion of the catheter plays an essential role in the development of thrombosis. Pharmacologic prophylaxis, including local anticoagulation with heparin-bonded catheter, has not been shown to reduce the risk of catheter-related thrombosis in children. Systemic anticoagulation in critically ill children started soon after the insertion of the catheter, however, may be beneficial. A multicenter clinical trial that is testing this hypothesis is currently underway.
中心静脉导管的存在和重症监护病房的入院是儿童深静脉血栓形成(DVT)的最重要危险因素。至少有 18%带有导管的危重病儿童会出现放射学确诊的导管相关血栓形成。有导管的危重病儿童中有 3%出现临床明显的血栓形成,与 8 天以上的机械通气相关。即使血栓最初无症状,有导管相关血栓形成的危重病儿童中也有 8%至 18%会发展为血栓后综合征。在危重病儿童中,插入无隧道导管后 24 小时内血栓形成并不常见,但几乎所有血栓在插入后 4 天内都已形成。导管插入过程中或之后的高凝状态在血栓形成中起重要作用。包括肝素结合导管局部抗凝在内的药物预防措施尚未证明可降低儿童导管相关血栓形成的风险。然而,在导管插入后不久开始对危重病儿童进行全身抗凝可能是有益的。目前正在进行一项多中心临床试验,以测试这一假设。